Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition

Efficacy and safety of 20% and 100% autologous serum eye drops in patients with severe dry eye disease: a prospective, blinded, randomized, crossover study.

The ocular surface·2026

Drug-Free Remission in Early Peripheral Spondyloarthritis, Including Psoriatic Arthritis: 10-Year Follow-Up From the CRESPA Trial.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Increased CCL22 production in early rheumatoid arthritis development with potential impact on mucosal autoimmunity, joint inflammation and T cell recruitment to LAMP3+ dendritic cells.

Journal of autoimmunity·2026

Optimizing Efficacy to Safety Ratio of Glucocorticoids in Rheumatoid Arthritis Models by Leveraging Peroxisome Proliferator-Activated Nuclear Receptor-α Agonism.

Arthritis & rheumatology (Hoboken, N.J.)·2026

T cell senescence and exhaustion: molecular mechanisms and immune rejuvenation for cancer immunotherapy.

Signal transduction and targeted therapy·2026

Adrenergic stimulation of bone marrow immunity differentially affects myeloma growth and immunotherapy responses.

Cancer letters·2026

Mitochondrial dysfunction in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using venetoclax.

Haematologica·2026

In vivo efficacy of the novel anti-microtubule inhibitor E7130 in preclinical models of early T-cell precursor acute lymphoblastic leukemia.

Haematologica·2026

Menin inhibition with revumenib clears measurable residual disease in acute myeloid leukemia with UBTF tandem duplication after allogeneic stem cell transplantation.

Haematologica·2026

Risk of immune thrombocytopenia following COVID-19 vaccination and SARS-CoV-2 infection.

Haematologica·2026

Degrading the BTK and blocking BCL2: a new path in marginal zone lymphomas.

Haematologica·2026

Human cell models for inherited platelet disorders: strengths, limitations and emerging technologies.

Haematologica·2026

Bruton Tyrosine Kinase Inhibitors in Immune-Mediated Skin Diseases: Current Evidence and Future Directions.

International journal of molecular sciences·2026

Hypothyroidism and Thyroxine-Induced Hyperthyroidism Differentially Affect Cathepsins, Mct8, and Thyroid Tissue Architecture in Male Mice.

International journal of molecular sciences·2026

To Be or Not to Be-Thymocyte Survival and Death in the Thymic Medulla.

International journal of molecular sciences·2026

Macrophage Density Patterns in Uterine Leiomyomas Across Patient Age Groups: Evaluation of Separately Quantified CD68-Positive and CD163-Positive Cells.

Current issues in molecular biology·2026

Transcriptomic Convergence Reveals Tumour-Specific Stromal Remodelling in Immune-Enriched Papillary Thyroid Carcinoma.

Cancers·2026

MRI-Based Prediction of Immunotherapy Response in Breast Cancer: A Systematic Review.

Cancers·2026

Related Experiment Videos

Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1

Related Concept Videos

Efficacy and safety of 20% and 100% autologous serum eye drops in patients with severe dry eye disease: a prospective, blinded, randomized, crossover study.

Drug-Free Remission in Early Peripheral Spondyloarthritis, Including Psoriatic Arthritis: 10-Year Follow-Up From the CRESPA Trial.

Increased CCL22 production in early rheumatoid arthritis development with potential impact on mucosal autoimmunity, joint inflammation and T cell recruitment to LAMP3+ dendritic cells.

Optimizing Efficacy to Safety Ratio of Glucocorticoids in Rheumatoid Arthritis Models by Leveraging Peroxisome Proliferator-Activated Nuclear Receptor-α Agonism.

T cell senescence and exhaustion: molecular mechanisms and immune rejuvenation for cancer immunotherapy.

Adrenergic stimulation of bone marrow immunity differentially affects myeloma growth and immunotherapy responses.

Mitochondrial dysfunction in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using venetoclax.

In vivo efficacy of the novel anti-microtubule inhibitor E7130 in preclinical models of early T-cell precursor acute lymphoblastic leukemia.

Menin inhibition with revumenib clears measurable residual disease in acute myeloid leukemia with UBTF tandem duplication after allogeneic stem cell transplantation.

Risk of immune thrombocytopenia following COVID-19 vaccination and SARS-CoV-2 infection.

Degrading the BTK and blocking BCL2: a new path in marginal zone lymphomas.

Human cell models for inherited platelet disorders: strengths, limitations and emerging technologies.

Bruton Tyrosine Kinase Inhibitors in Immune-Mediated Skin Diseases: Current Evidence and Future Directions.

Hypothyroidism and Thyroxine-Induced Hyperthyroidism Differentially Affect Cathepsins, Mct8, and Thyroid Tissue Architecture in Male Mice.

To Be or Not to Be-Thymocyte Survival and Death in the Thymic Medulla.

Macrophage Density Patterns in Uterine Leiomyomas Across Patient Age Groups: Evaluation of Separately Quantified CD68-Positive and CD163-Positive Cells.

Transcriptomic Convergence Reveals Tumour-Specific Stromal Remodelling in Immune-Enriched Papillary Thyroid Carcinoma.

MRI-Based Prediction of Immunotherapy Response in Breast Cancer: A Systematic Review.

Related Experiment Videos

Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1...

Related Concept Videos

Related Articles

Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1